165 related articles for article (PubMed ID: 33890983)
21. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
[TBL] [Abstract][Full Text] [Related]
22. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
23. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
25. Role of stereotaxically injected IgG from db/db mice in the phosphorylation of the microtubule-associated protein tau in hippocampus.
Shuai H; Zhang J; Zhang J; Xie J; Zhang M; Ma J; Zhang L; Wang X
Brain Res; 2012 Nov; 1486():14-26. PubMed ID: 23036273
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
27. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
28. mTORC2 is the hydrophobic motif kinase for SGK1.
Yan L; Mieulet V; Lamb RF
Biochem J; 2008 Dec; 416(3):e19-21. PubMed ID: 19025518
[TBL] [Abstract][Full Text] [Related]
29. High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.
Knight EM; Martins IV; Gümüsgöz S; Allan SM; Lawrence CB
Neurobiol Aging; 2014 Aug; 35(8):1821-32. PubMed ID: 24630364
[TBL] [Abstract][Full Text] [Related]
30. Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet.
Huang DY; Boini KM; Osswald H; Friedrich B; Artunc F; Ullrich S; Rajamanickam J; Palmada M; Wulff P; Kuhl D; Vallon V; Lang F
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1264-73. PubMed ID: 17003223
[TBL] [Abstract][Full Text] [Related]
31. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW
Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
[TBL] [Abstract][Full Text] [Related]
33. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.
Leboucher A; Laurent C; Fernandez-Gomez FJ; Burnouf S; Troquier L; Eddarkaoui S; Demeyer D; Caillierez R; Zommer N; Vallez E; Bantubungi K; Breton C; Pigny P; Buée-Scherrer V; Staels B; Hamdane M; Tailleux A; Buée L; Blum D
Diabetes; 2013 May; 62(5):1681-8. PubMed ID: 23250356
[TBL] [Abstract][Full Text] [Related]
34. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
[TBL] [Abstract][Full Text] [Related]
35. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal overexpression of SGK1 ameliorates spatial memory, rescues Aβ pathology and actin cytoskeleton polymerization in middle-aged APP/PS1 mice.
Lian B; Liu M; Lan Z; Sun T; Meng Z; Chang Q; Liu Z; Zhang J; Zhao C
Behav Brain Res; 2020 Apr; 383():112503. PubMed ID: 31981651
[TBL] [Abstract][Full Text] [Related]
37. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
38. Akt3 inhibits adipogenesis and protects from diet-induced obesity via WNK1/SGK1 signaling.
Ding L; Zhang L; Biswas S; Schugar RC; Brown JM; Byzova T; Podrez E
JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202451
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
40. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
